G. Petranyi, NS. Ryder; A. Stütz, Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase., in Science, vol. 224, n. 4654, Giu 1984, pp. 1239-41, PMID6547247.
NS. Ryder, MC. Dupont, Inhibition of squalene epoxidase by allylamine antimycotic compounds. A comparative study of the fungal and mammalian enzymes., in Biochem J, vol. 230, n. 3, Set 1985, pp. 765-70, PMID3877503.
NS. Ryder, G. Seidl; PF. Troke, Effect of the antimycotic drug naftifine on growth of and sterol biosynthesis in Candida albicans., in Antimicrob Agents Chemother, vol. 25, n. 4, aprile 1984, pp. 483-7, PMID6375557.
NH. Georgopapadakou, BA. Dix; SA. Smith; J. Freudenberger; PT. Funke, Effect of antifungal agents on lipid biosynthesis and membrane integrity in Candida albicans., in Antimicrob Agents Chemother, vol. 31, n. 1, gennaio 1987, pp. 46-51, PMID3551826.
A. Kecskes, P. Jahn, [Assessment of the antiphlogistic effect of naftifin-HCl in the UV-B erythema test]., in Hautarzt, vol. 40, n. 3, marzo 1989, pp. 158-60, PMID2654080.
EG. Evans, IG. James; RA. Seaman; MD. Richardson, Does naftifine have anti-inflammatory properties? A double-blind comparative study with 1% clotrimazole/1% hydrocortisone in clinically diagnosed fungal infection of the skin., in Br J Dermatol, vol. 129, n. 4, Ott 1993, pp. 437-42, PMID8217759.
AH. Faruqi, KA. Khan; AA. Qazi; TS. Haroon, In vitro antifungal activity of naftifine: (SN 105-843 GEL) against dermatophytes., in J Pak Med Assoc, vol. 31, n. 12, Dic 1981, pp. 279-82, PMID6806496.
A. Georgopoulos, G. Petranyi; H. Mieth; J. Drews, In vitro activity of naftifine, a new antifungal agent., in Antimicrob Agents Chemother, vol. 19, n. 3, marzo 1981, pp. 386-9, PMID7247366.
R. Czok, Preclinical evaluation of Exoderil (naftifine). Part II. Mechanism of action, absorption, metabolism and excretion, in Mykosen, n. 30, 1987, pp. 32-7, PMID3550458.
RB. Stoughton, J. Sefton; L. Zeleznick, In vitro and in vivo cutaneous penetration and antifungal activity of naftifine., in Cutis, vol. 44, n. 4, Ott 1989, pp. 333-5, PMID2805810.
U. Ganzinger, A. Stutz; G. Petranyi; A. Stephen, Allylamines: topical and oral treatment of dermatomycoses with a new class of antifungal agents., in Acta Derm Venereol Suppl (Stockh), vol. 121, 1986, pp. 155-60, PMID3459341.
R. Weiss, H. Krauss; M. Kaps, [Electron microscopy demonstration of the capsule of Cryptococcus neoformans]., in Mykosen, vol. 30, n. 2, febbraio 1987, pp. 57-63, PMID3553928.
S. Nolting, G. Weidinger, [Naftifin in severe dermatomycosis--controlled comparison of efficacy with econazole]., in Mykosen, vol. 28, n. 2, febbraio 1985, pp. 69-76, PMID3885027.
LE. Millikan, WK. Galen; GB. Gewirtzman; SN. Horwitz; RK. Landow; LT. Nesbitt; HL. Roth; J. Sefton; RM. Day, Naftifine cream 1% versus econazole cream 1% in the treatment of tinea cruris and tinea corporis., in J Am Acad Dermatol, vol. 18, 1 Pt 1, gennaio 1988, pp. 52-6, PMID3279083.
CT. Lee, YC. Giam; T. Tan, The use of naftifine (Exoderil) cream in the treatment of dermatophytosis., in Singapore Med J, vol. 28, n. 5, Ott 1987, pp. 429-31, PMID3324355.
K. Meinicke, C. Striegel; G. Weidinger, [Treatment of dermatomycosis with naftifin. Therapeutic effectiveness following once and twice daily administration]., in Mykosen, vol. 27, n. 12, Dic 1984, pp. 608-14, PMID6395017.
PJ. Haas, H. Tronnier; G. Weidinger, [Naftifin in foot mycoses. Double-blind therapeutic comparison with clotrimazole]., in Mykosen, vol. 28, n. 1, gennaio 1985, pp. 33-40, PMID3883160.
A. Bojanovsky, P. Haas, [Antimycotic effect of naftifin in tinea pedis. Comparative double-blind study with bifonazole]., in Fortschr Med, vol. 103, n. 25, Lug 1985, pp. 677-9, PMID3897005.
F. Klaschka, H. Gartmann; G. Weidinger, [The antifungal agent naftifin. Placebo-controlled therapeutic comparison in tinea pedis]., in Z Hautkr, vol. 59, n. 18, Set 1984, pp. 1218-26, PMID6388170.
EB. Smith, K. Wiss; JM. Hanifin; RE. Jordon; RP. Rapini; AE. Lasser; MB. Kirschenbaum; LE. Millikan; LC. Parish; MJ. Rapaport, Comparison of once- and twice-daily naftifine cream regimens with twice-daily clotrimazole in the treatment of tinea pedis., in J Am Acad Dermatol, vol. 22, 6 Pt 1, Giu 1990, pp. 1116-7, PMID2370340.
EB. Smith, DL. Breneman; RF. Griffith; AA. Hebert; JG. Hickman; JM. Maloney; LE. Millikan; VI. Sulica; SH. Dromgoole; J. Sefton, Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis., in J Am Acad Dermatol, vol. 26, n. 1, gennaio 1992, pp. 125-7, PMID1732321.
Naftifine cream 1% versus clotrimazole cream 1% in the treatment of tinea pedis. Naftifine Podiatric Study Group., in J Am Podiatr Med Assoc, vol. 80, n. 6, Giu 1990, pp. 314-8, PMID2189989.
H. Senff, S. Tholen; W. Stieler; D. Reinel; BM. Hausen, Allergic contact dermatitis to naftifine. Report of two cases., in Dermatologica, vol. 178, n. 2, 1989, pp. 107-8, PMID2522401.
E. Hoting, B. Küchmeister; BM. Hausen, [Contact allergy to the antifungal agent naftifin]., in Derm Beruf Umwelt, vol. 35, n. 4, pp. 124-7, PMID2959458.
JJ. Goday, M. González-Güemes; I. Yanguas; R. Ilardia; R. Soloeta, Allergic contact dermatitis from naftifine in a child without cross-reaction to terbinafine., in J Eur Acad Dermatol Venereol, vol. 11, n. 1, Lug 1998, pp. 72-3, PMID9731972.
C. Willa-Craps, M. Wyss; P. Elsner, Allergic contact dermatitis from naftifine., in Contact Dermatitis, vol. 32, n. 6, Giu 1995, pp. 369-70, PMID7554894.
R. Sannerstedt, P. Lundborg; BR. Danielsson; I. Kihlström; G. Alván; B. Prame; E. Ridley, Drugs during pregnancy: an issue of risk classification and information to prescribers., in Drug Saf, vol. 14, n. 2, febbraio 1996, pp. 69-77, PMID8852521.